Sauvagine TFA is primarily used in research settings to study stress responses and related physiological processes. It acts as a potent agonist for corticotropin-releasing factor (CRF) receptors, making it valuable in investigating the role of CRF in anxiety, depression, and stress-related disorders. Researchers utilize it to explore the hypothalamic-pituitary-adrenal (HPA) axis and its regulation. Additionally, it is employed in neuropharmacology studies to understand the mechanisms of CRF receptor signaling and its potential therapeutic targets for mood and stress-related conditions. Its application extends to behavioral studies in animal models to assess stress-induced behaviors and their modulation.